Abstract:Background: Iron deficiency is a highly prevalent micronutrient abnormality and the most common cause of anemia globally, worsening the burden of adverse pregnancy and child outcomes. Objective: We sought to evaluate the response of hematologic biomarkers to iron supplementation and to examine the predictors of the response to iron supplementation among iron-deficient pregnant women. Methods: We identified 600 iron-deficient (serum ferritin ≤12 μg/L) pregnant women, aged 18-45 y, presenting to 2 antenatal clinics in Dar es Salaam, Tanzania using rapid ferritin screening tests, and prospectively followed them through delivery and postpartum. All women received 60 mg Fe and 0.25 mg folate daily from enrollment until delivery. Proportions meeting the thresholds representing deficient hematologic status including hemoglobin <110 g/L, ferritin ≤12 μg/L, serum soluble transferrin receptor (sTfR) >4.4 mg/L, zinc protoporphyrin (ZPP) >70 mmol/L, or hepcidin ≤13.3 μg/L at baseline and delivery were assessed. The prospective change in biomarker concentration and the influence of baseline hematologic status on the change in biomarker concentrations were assessed. Regression models were estimated to assess the relation of change in biomarker concentrations and pregnancy outcomes. Results: There was significant improvement in maternal biomarker concentrations between baseline and delivery, with increases in the concentrations of hemoglobin (mean difference: 15.2 g/L; 95% CI: 13.2, 17.2 g/L), serum ferritin (51.6 μg/L; 95% CI: 49.5, 58.8 μg/L), and serum hepcidin (14.0 μg/L; 95% CI: 12.4, 15.6 μg/L) and decreases in sTfR (-1.7 mg/L; 95% CI: -2.0, -1.3 mg/L) and ZPP (-17.8 mmol/L; 95% CI: -32.1, 3.5 mmol/L). The proportions of participants with low hemoglobin, ferritin, and hepcidin were 73%, 93%, and 99%, respectively, at baseline and 34%, 12%, and 46%, respectively, at delivery. The improvements in biomarker concentrations were significantly greater among participants with poor hematologic status at baseline - up to 12.1 g/L and 14.5 μg/L for hemoglobin and ferritin concentrations, respectively. For every 10-g/L increase in hemoglobin concentration, there was a 24% reduced risk of perinatal mortality (RR = 0.76; 95% CI: 0.59, 0.99) and a 23% reduced risk of early infant mortality (RR = 0.77; 95% CI: 0.60, 0.99). The risk of anemia at delivery despite supplementation was predicted by baseline anemia (RR = 2.11; 95% CI: 1.39, 3.18) and improvements in ferritin concentration were more likely to be observed in participants who took iron supplements for up to 90 d (RR = 1.41; 95% CI: 1.13, 1.76). Conclusion: Iron supplementation decreases the risk of maternal anemia and increases the likelihood of infant survival among iron-deficient Tanzanian pregnant women. Interventions to promote increased duration and adherence to iron supplements may also provide greater health benefits.

[Effect of Iron Supplementation on Iron Deficiency Anemia of Childbearing Age Women in Shanghai].

Iron Supplementation Affects Hematologic Biomarker Concentrations and Pregnancy Outcomes among Iron-Deficient Tanzanian Women

Study on the changes of RBC, Hct, and Ret levels in patients with anemia during pregnancy and clinical treatment

Evaluation on effect of improved iron nutrition of pregnant women with intermittent iron supplementation

[The Influence of Preventive Iron Supplementation to Iron Nutritional Status in Breastfed Infants].

Prenatal Iron Supplementation Reduces Maternal Anemia, Iron Deficiency, And Iron Deficiency Anemia In A Randomized Clinical Trial In Rural China, But Iron Deficiency Remains Widespread In Mothers And Neonates

Maternal iron intake during pregnancy and birth outcomes: a cross-sectional study in Northwest China.

Iron-containing Micronutrient Supplementation of Chinese Women with No or Mild Anemia During Pregnancy Improved Iron Status but Did Not Affect Perinatal Anemia.

EFFECT OF VITAMIN A AND IRON SUPPLEMENTATION ON IRON STATUS DURING PREGNANCY

Prenatal Iron Containing Supplements Provided to Chinese Women with No or Mild Anemia Had No Effect on Hemoglobin Concentration in Post-Partum Women or Their Infants at 6 and 12 Months of Age

Micronutrient Supplementation and Pregnancy Outcomes: Double-Blind Randomized Controlled Trial in China.

Prenatal Supplementations of Iron, Iron-Containing Multimicronutrients and Antianemic Chinese Patent Medicines in Women in Shaanxi Province, 2010-2013

[Iron Status and Effect of Early Iron Supplementation on Sub-Clinical Iron Deficiency in Rural School-Age Children from Mountainous Areas of Beijing].

A Retrospective Case-Control Study of the Determinants of Iron Deficiency Anemia in Infants in an Urban Community in Shanghai China Between 2010-2015

Low-Dose Iron Supplementation in Infancy Modestly Increases Infant Iron Status at 9 Mo Without Decreasing Growth or Increasing Illness in a Randomized Clinical Trial in Rural China.

[Survey of Prevalence of Iron Deficiency and Iron Deficiency Anemia in Pregnant Women in Urban Areas of China].

[Effects of Iron Supplementation on Human Serum Level of Transferrin Receptor].

Impact of Iron‐containing Micronutrient Supplementation on High Hemoglobin Concentration During Pregnancy

[Analysis on the Iron Status and Associated Factors During the First Trimester of Pregnancy].

The interactions between maternal iron supplementation and iron metabolism-related genetic polymorphisms on birth outcomes: a prospective study in Chinese

Distribution of iron status among urban Chinese women